Frontiers in Immunology (Jul 2025)
Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
- Xiaoting Lin,
- Xiaoting Lin,
- Xiaoting Lin,
- Xiaoting Lin,
- Peng Liu,
- Peng Liu,
- Peng Liu,
- Peng Liu,
- Guoyan Qi,
- Guoyan Qi,
- Guoyan Qi,
- Guoyan Qi
Affiliations
- Xiaoting Lin
- Department of Oncology, Hebei Medical University, Shijiazhuang, Hebei, China
- Xiaoting Lin
- Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
- Xiaoting Lin
- Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, China
- Xiaoting Lin
- Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, China
- Peng Liu
- Department of Oncology, Hebei Medical University, Shijiazhuang, Hebei, China
- Peng Liu
- Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
- Peng Liu
- Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, China
- Peng Liu
- Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, China
- Guoyan Qi
- Department of Oncology, Hebei Medical University, Shijiazhuang, Hebei, China
- Guoyan Qi
- Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
- Guoyan Qi
- Hebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, China
- Guoyan Qi
- Hebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, China
- DOI
- https://doi.org/10.3389/fimmu.2025.1650718
- Journal volume & issue
-
Vol. 16
Abstract
No abstracts available.Keywords
